First Sputnik V vaccine batch successfully produced in Vietnam
The Health Ministry’s Company for Vaccine and Biological Production No.1 (Vabiotech) announced on September 24 that it has successfully produced the first batch of Sputnik V vaccine in Vietnam.
Hanoi (VNA) – The Health Ministry’s Companyfor Vaccine and Biological Production No.1 (Vabiotech) announced onSeptember 24 that it has successfully produced the first batch of Sputnik Vvaccine in Vietnam.
The batch coded SV-030721M was tested on August 26 by the GamaleyaResearch Institute of Epidemiology and Microbiology - developer of the Sputnik V vaccine, and met quality requirements.
Vabiotech President Do Tuan Dat said the company will import semi-finished Sputnik V vaccine this month to pack them, thus helping Vietnam becomeself-sufficient in Sputnik V vaccine supply.
The vaccine makesuse of heterogeneous boosting, meaning that it employs two different vectorsover the course of the two shots, which the developer claims to providelonger immunity than ones that use the same delivery mechanism. The gapbetween two shots is three weeks.
According to theclinical test result announced on “The Lancet” magazine, Sputnik V’s efficacyamounts to 91.6 percent. After injection, 98 percent of volunteers produce antibodiesagainst the virus.
The VietnameseHealth Ministry granted conditional approval of Sputnik V for emergency use onMarch 23. Later on July 21, Vabiotech officially announced the production ofSputnik V vaccine on a trial basis.
Dat added thatVabiotech is also pushing forward the registration of Sputnik Light vaccinethat only need📖s one shot./.
The Government has issued Resolution 73/NQ-CP on the procurement of Russia’s Sputnik V COVID-19 vaccine, which approved the Ministry of Health’s proposal for the negotiation for 40 million doses.
Minister of Health Nguyen Thanh Long has sent a letter to Russian Direct Investment Fund (RDIF) to introduce T&t Group as the negotiator for the purchase of 40 million doses of Sputnik V COVID-19 vaccine from Russia.
VABIOTECH, one of Vietnam’s leading pharmaceutical companies, and the Russian Direct Investment Fund (RDIF) on July 21 announced the production of a test batch of the Russian Sputnik V vaccine against the coronavirus in Vietnam.
Philippine authorities announced that the Food and Drug Administration (FDA) has approved the emergency use of Russia's Sputnik Light COVID-19 vaccine, making it the first country in Southeast Asia to approve this single-dose vaccine.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Photo: Vabiotech) 
